J&J to pay $50 million to Emergent to resolve manufacturing deal for COVID vaccine-March 2024-www.financetom.com

J&J to pay $50 million to Emergent to resolve manufacturing deal for COVID vaccine

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J to pay $50 million to Emergent to resolve manufacturing deal for COVID vaccine

Jul 8, 2024 2:45 PM

July 8 (Reuters) - Emergent BioSolutions ( EBS ) said on

Monday Johnson & Johnson has agreed to pay $50 million

to settle claims related to a terminated manufacturing deal for

the latter's COVID-19 vaccine.

Previous page： FirstEnergy misses first-quarter profit estimates on unfavorable weather Next page： Atlassian Insider Sold Shares Worth $1,645,777, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

FirstEnergy misses first-quarter profit estimates on unfavorable weather

Apr 25, 2024

April 25 (Reuters) - Utility firm FirstEnergy ( FE ) missed first-quarter profit estimates on Thursday on account of unfavorable weather and higher interest expense. Milder-than-usual winter in the areas where FirstEnergy ( FE ) operates dragged down customers' need for electricity to keep themselves warm during the colder months. While heating degree days were 5% higher than the historically...

Atlassian Insider Sold Shares Worth $1,645,777, According to a Recent SEC Filing

Apr 25, 2024

05:15 PM EDT, 04/25/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on April 24, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,645,777. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 366,450 shares of the company, with 366,450 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024003522/xslF345X03/primarydocument.xml Price: 186.55, Change: -11.86, Percent...

Erie Indemnity Q1 Earnings, Revenue Rise

Apr 25, 2024

05:18 PM EDT, 04/25/2024 (MT Newswires) -- Erie Indemnity ( ERIE ) reported Q1 earnings late Thursday of $2.38 per diluted share, up from $1.65 a year earlier. One analyst surveyed by Capital IQ expected $2.33. Operating revenue for the quarter ended March 31 was $880.7 million, up from $752.5 million a year earlier. One analyst surveyed by Capital IQ...

Fair Isaac Fiscal Q2 Non-GAAP Earnings, Revenue Increase -- Shares Down After Hours

Apr 25, 2024

05:15 PM EDT, 04/25/2024 (MT Newswires) -- Fair Isaac ( FICO ) reported fiscal Q2 non-GAAP earnings late Thursday of $6.14 per diluted share, up from $4.78 a year earlier. Analysts polled by Capital IQ expected $5.81. Revenue for the quarter that ended March 31 was $433.8 million, up from $380.3 million a year earlier. Analysts surveyed by Capital IQ...